Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Viridian Therapeutics announced that its innovative drug Lumvoa™ (generic name: veligrotug-vvze) has been approved by the U.S. Food and Drug Administration (FDA) and officially launched for the treatment of Thyroid Eye Disease (TED).

Viridian Therapeutics announced that its innovative drug Lumvoa™ (generic name: veligrotug-vvze) has been approved by the U.S. Food and Drug Administration (FDA) and officially launched for the treatment of Thyroid Eye Disease (TED).

老虎证券老虎证券2026/06/26 22:23
Show original
This approval marks a significant advancement for Viridian Therapeutics in the field of ophthalmic treatments. Lumvoa™ is a biologic targeting specific targets, and its approval offers a new treatment option for patients with thyroid eye disease. Thyroid eye disease is an autoimmune disorder associated with thyroid dysfunction, causing symptoms such as eye protrusion, double vision, impaired vision, and others, which severely impact patients' quality of life. The launch of this new drug is expected to address unmet medical needs in this disease area.The company stated it will promptly initiate the commercialization process for Lumvoa™ in the United States, ensuring that the drug can benefit patients in need as soon as possible. This approval is based on multiple clinical study data, which demonstrate the effectiveness and safety of the therapy in improving disease signs and symptoms.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Sector Update: Energy Stocks Higher Late Afternoon

03:55 PM EDT, 10/05/2026 (MT Newswires) -- Energy stocks advanced late Monday afternoon, with the NYSE Energy Sector Index rising 1.1% and the State Street Energy Select Sector SPDR ETF (XLE) adding 0.8%. The Philadelphia Oil Service Sector Index was climbing 3.6%, and the Dow Jones US Utilities Index increased 0.6%. In geopolitical news, Saudi Arabia-backed Yemeni government forces advanced on Monday to retake the coast around the Bab el-Mandeb Strait, a chokepoint similar to the Strait of Hormuz, pushing the Iran-backed Houthis out of most of the areas they had seized in September, Reuters reported. Meanwhile, Iran's Interior Minister Eskandar Momeni travelled to Doha at the invitation of his Qatari counterpart, Al Jazeera reported. Front-month West Texas Intermediate crude oil fell 2.2% to $89.07 a barrel, and the global benchmark Brent crude contract shed 2.1% to $100.07 a barrel. Henry Hub natural gas futures rose 0.9% to $3.06 per 1 million BTU. In corporate news, Cenovus Energy (CVE) has agreed to buy fellow Canadian energy company Athabasca Oil in a cash-and-stock deal with an implied enterprise value of roughly 5.7 billion Canadian dollars ($4 billion), as it aims to expand its core oil sands business. Cenovus shares were down 2.9%. Chevron (CVX) said Jeff Gustavson, who currently serves as president of its New Energies unit, has been appointed as chief financial officer, effective Jan. 1, 2027. Shares eased 0.3%. Suncor Energy (SU) agreed to sell its interests in the Terra Nova, White Rose and West White Rose offshore assets to Ithaca Energy for 1.2 billion Canadian dollars ($841.3 million) in upfront cash, plus up to CA$350 million in contingent payments, Suncor said Sunday. Suncor shares were down 1.1%. BP (BP) CEO Meg O'Neill said Monday that the company has adjusted its refineries to maximize diesel production amid sharper prices of the commodity. Speaking at the Energy Intelligence conference in London, O'Neill said that the company has been able to adapt and respond to changing customer needs. BP

MT newswire•2026/10/05 19:55

US-India trade negotiations reach a stalemate, Indian Finance Minister: “The talks have reached a plateau,” with extremely limited room for concessions

Indian Finance Minister Nirmala Sitharaman stated on Monday that the negotiation process has been "tough and stringent", and both parties have now reached a "plateau", making it "extremely difficult" for either side to make further concessions or requests. However, she left room for flexibility, saying: "If there is still room for maneuver, both parties will pursue it." Last Friday, US Trade Representative Jamieson Greer said that the negotiations were in their "final stages", but emphasized that a final agreement was not "imminent".

华尔街见闻•2026/10/05 19:41

Raia Drogasil controlador stake slips R$ 11.23 million after September cash share sales

Raia Drogasil internal dealing filings for 09/2026 showed spot share sales by the majority shareholder, totaling 624,000 shares for R$ 12.63 million. Weighted average sale price for the majority shareholder’s spot trades was R$ 20.2389 per share. Executives also reported spot share sales of 50,000 shares for R$ 1,016,435 at a weighted average price of R$ 20.3287. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raia Drogasil SA published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/05 19:40